| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |